Information Mediary Corp (IMC) and Adherence have joined forces to unveil a novel digitized Morisky Medication Adherence Scale (MMAS), reshaping the landscape of medication adherence management. The introduction of this cutting-edge solution represents a major breakthrough in precision and effectiveness in patient care, ultimately enhancing treatment outcomes and overall health.
The MMAS, known as the gold standard for evaluating medication adherence, has made its mark in the medical field by being referenced in over 31,298 academic journals. Through this collaboration, IMC and Adherence have combined IMC’s advanced dose analytics with Adherence’s expertise to create a solution that integrates patient-reported MMAS data with objective adherence information. This integration will be seamlessly incorporated into the CertiScan Adherence Insight Platform, eCAP, and Med-ic, offering partners a comprehensive set of tools for enhanced adherence monitoring and improved patient results.
A key focus of this partnership is the development of APIs for third-party platform integration, enabling healthcare industry partners to benefit from this innovative solution in a variety of healthcare settings. Dean BrotzelCTO of IMC, expressed enthusiasm about this digital MMAS integration, highlighting the transformative impact it will have on medication adherence monitoring for healthcare providers and patients alike.
For further information on this groundbreaking collaboration between IMC and Adherence, please visit their websites or make inquiries through the provided contacts.
IMC, a leader in smart packaging technology for patient safety and improved healthcare outcomes, has a proven track record of success, as evidenced by the utilization of their Med-ic® Smart Dose blister in FDA-approved clinical trials with major pharmaceutical companies. Adherence, on the other hand, is known for its development and integration of the MMAS into various healthcare research, clinical practices, and patient intake protocols, playing a key role in identifying patients at risk of non-adherence and guiding customized adherence interventions.
The partnership between IMC and Adherence is set to revolutionize medication adherence management and bring about positive changes in patient care. With a focus on precision, efficiency, and integration with third-party platforms, this collaboration is paving the way for improved healthcare outcomes and patient well-being.
Source link
